Cutera EBITDA 2010-2023 | CUTR
Cutera ebitda from 2010 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Cutera Annual EBITDA
(Millions of US $) |
| 2022 |
$-31 |
| 2021 |
$6 |
| 2020 |
$-19 |
| 2019 |
$-8 |
| 2018 |
$-10 |
| 2017 |
$12 |
| 2016 |
$3 |
| 2015 |
$-3 |
| 2014 |
$-9 |
| 2013 |
$-4 |
| 2012 |
$-5 |
| 2011 |
$-10 |
| 2010 |
$-10 |
| 2009 |
$-9 |
Cutera Quarterly EBITDA
(Millions of US $) |
| 2023-09-30 |
$-35 |
| 2023-06-30 |
$-27 |
| 2023-03-31 |
$-22 |
| 2022-12-31 |
$-3 |
| 2022-09-30 |
$-8 |
| 2022-06-30 |
$-9 |
| 2022-03-31 |
$-12 |
| 2021-12-31 |
$-1 |
| 2021-09-30 |
$2 |
| 2021-06-30 |
$3 |
| 2021-03-31 |
$2 |
| 2020-12-31 |
$2 |
| 2020-09-30 |
$-0 |
| 2020-06-30 |
$-10 |
| 2020-03-31 |
$-11 |
| 2019-12-31 |
$-1 |
| 2019-09-30 |
$-1 |
| 2019-06-30 |
$1 |
| 2019-03-31 |
$-7 |
| 2018-12-31 |
$-5 |
| 2018-09-30 |
$-0 |
| 2018-06-30 |
$-1 |
| 2018-03-31 |
$-4 |
| 2017-12-31 |
$5 |
| 2017-09-30 |
$6 |
| 2017-06-30 |
$2 |
| 2017-03-31 |
$-1 |
| 2016-12-31 |
$5 |
| 2016-09-30 |
$2 |
| 2016-06-30 |
$-1 |
| 2016-03-31 |
$-2 |
| 2015-12-31 |
$2 |
| 2015-09-30 |
$-1 |
| 2015-06-30 |
$-2 |
| 2015-03-31 |
$-3 |
| 2014-12-31 |
$-1 |
| 2014-09-30 |
$-2 |
| 2014-06-30 |
$-3 |
| 2014-03-31 |
$-3 |
| 2013-12-31 |
$-0 |
| 2013-09-30 |
$-2 |
| 2013-06-30 |
$-0 |
| 2013-03-31 |
$-2 |
| 2012-12-31 |
$1 |
| 2012-09-30 |
$-1 |
| 2012-06-30 |
$-1 |
| 2012-03-31 |
$-5 |
| 2011-12-31 |
$-1 |
| 2011-09-30 |
$-2 |
| 2011-06-30 |
$-3 |
| 2011-03-31 |
$-4 |
| 2010-12-31 |
$-1 |
| 2010-09-30 |
$-3 |
| 2010-06-30 |
$-4 |
| 2010-03-31 |
$-2 |
| 2009-12-31 |
$-0 |
| 2009-09-30 |
$-1 |
| 2009-06-30 |
$-4 |
| 2009-03-31 |
$-3 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Laser Systems and Components |
$0.039B |
$0.212B |
|
Cutera Inc designs, develops, manufactures and markets the CoolGlide family of products for use in laser and other light-based aesthetic applications. The original CoolGlide CV provides permanent hair reduction on all skin types. The second generation CoolGlide Excel incorporated features that added the capability to treat a variety of vascular lesions, which include facial telangiectasia, spider and reticular leg veins. The CoolGlide Vantage added non-ablative skin therapy to the range of applications offered by the system.
|
